SkinBioTherapeutics plc (SBTX) Ord GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




16.25p
16.50p
27.50p
£42.05 million
16.25p
16.00p
10.25p
n/a
0.00p (0.00%) Previous:
0.00p
313,258
n/a
30,000
Performance
1 week 1W | 4.84% | 1 year 1Y | 28.71% |
---|---|---|---|
1 month 1M | 13.04% | 2 years 2Y | 27.78% |
3 months 3M | 5.8% | 3 years 3Y | 9.72% |
6 months 6M | 35% | 5 years 5Y | 11.93% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 30/06/2024 | 30/06/2023 |
---|---|---|
Revenue (£m) | 1.21 | 0.13 |
Profit before tax (£m) | (2.95) | (3.01) |
Adjusted EPS (p): | (1.54) | (1.72) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
SkinBioTherapeutics revenue rises fourfold, still misses forecasts
14 August 2025 13:48
-
SkinBioTherapeutics inks Superdrug deal, raises £4.1m
16 June 2025 16:14
-
SkinBioTherapeutics shares jump on acquisition of topical cream maker
11 October 2024 08:41
-
FY Trading Update
14 August 2025 07:00
-
Croda Commercial Launch Progressing as Expected
30 June 2025 07:00
-
Notice of IMC Shareholder Presentation
27 June 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.